Caplin Point continues to rise

Caplin Point Labs did very well yesterday and today too, it continues to do well. Yesterday, it had breached the upper circuit at Rs.264.25 and today, it opened higher at Rs.266 levels and is currently at Rs.273, up 4.6%.

The stock is up after the company yesterday announced that its plant at Pondicherry had commenced its additional line of production in the area of suppositories. The company has stated that this is unique in its feature which very few pharma companies have. This will now enable export of these products to semi regulated and non regulated markets which includes Dominican Republic, Guatemala, Nicaragua, El Salvador, Honduras, in Latin American countries & Angola, Mali in West African countries.